Bessemer to sell $11.1M in Hinge Health shares

Hinge Health, Inc. (HNGE) received a Rule 144 notice that Bessemer Venture Partners X intends to sell up to 128,950 Class A shares through Merrill Lynch.

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) received a Rule 144 notice that Bessemer Venture Partners X intends to sell up to 128,950 Class A shares through Merrill Lynch. The shares were acquired in a private placement from Hinge Health on 02/04/2020 for cash. Hinge Health had 62,468,721 Class A shares outstanding as of the notice, and the planned sale has an indicated aggregate market value of $11,130,964.

Key Figures

Shares to be sold: 128,950 shares Aggregate market value: $11,130,964 Shares outstanding: 62,468,721 shares +2 more

5 metrics

Shares to be sold 128,950 shares Class A shares Hinge Health, Inc. to be sold under Rule 144

Aggregate market value $11,130,964 Aggregate market value of the 128,950 Class A shares to be sold

Shares outstanding 62,468,721 shares Class A shares of Hinge Health, Inc. outstanding as of the notice

Acquisition date 02/04/2020 Date the 128,950 shares were acquired in a private placement

Planned sale date 08/19/2026 Date listed for the planned Rule 144 sale on NYSE

Key Terms

Rule 144, Private Placement, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Private Placement financial

"Class A | 02/04/2020 | Private Placement | Issuer"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

aggregate market value financial

"Class A | Merrill Lynch ... | 128950 | 11130964 | 62468721"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for Hinge Health, Inc. (HNGE)?

The filing reports that Bessemer Venture Partners X plans to sell up to 128,950 HNGE Class A shares under Rule 144. This reflects a potential secondary sale by an existing holder, not a new share issuance by Hinge Health.

How many HNGE shares are planned to be sold under this Form 144?

Bessemer Venture Partners X plans to sell up to 128,950 Class A shares of Hinge Health, Inc. The filing lists these shares with an aggregate market value of $11,130,964, to be sold through Merrill Lynch on or after August 19, 2026.

What is the aggregate market value of the HNGE shares in this Form 144?

The planned sale covers HNGE shares with an aggregate market value of $11,130,964. This value is tied to the 128,950 Class A shares that Bessemer Venture Partners X has notified for potential sale under Rule 144.

How many HNGE shares were outstanding at the time of this Form 144 notice?

At the time of the notice, Hinge Health, Inc. had 62,468,721 Class A shares outstanding. This figure provides context for the planned sale of 128,950 shares by Bessemer Venture Partners X under Rule 144.

When and how were the HNGE shares being sold originally acquired?

The 128,950 HNGE Class A shares were acquired on 02/04/2020 in a private placement transaction from Hinge Health, Inc. The Form 144 states that the consideration for this acquisition was cash paid on the same date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:34 PM EDT Accepted by SEC EDGAR 08/19/2026 - 04:33 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001768640
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET, 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Bessemer Venture Partners X LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Merrill Lynch One Bryant Park New York NY 10036	128950	11130964	62468721	08/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	02/04/2020	Private Placement	Issuer			128950	02/04/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Please see attached for securities sold over the last 3 months
Date of Notice	08/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Augie Wilkinson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)